IELUZZI, Donatella
 Distribuzione geografica
Continente #
NA - Nord America 775
EU - Europa 757
AS - Asia 281
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.819
Nazione #
US - Stati Uniti d'America 775
GB - Regno Unito 337
CN - Cina 215
IT - Italia 99
IE - Irlanda 70
SE - Svezia 68
FI - Finlandia 45
FR - Francia 44
RU - Federazione Russa 33
SG - Singapore 28
DE - Germania 26
KR - Corea 12
BE - Belgio 11
UA - Ucraina 11
VN - Vietnam 9
IN - India 7
EG - Egitto 3
GR - Grecia 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
EU - Europa 2
JP - Giappone 2
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
MA - Marocco 1
MY - Malesia 1
NL - Olanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.819
Città #
Southend 251
Chandler 129
Ann Arbor 122
Jacksonville 90
Dublin 70
Woodbridge 70
Houston 65
Beijing 64
Lancaster 54
Ashburn 46
Jinan 27
Wilmington 24
Singapore 21
Lawrence 18
Princeton 18
Nanjing 13
Kent 12
Verona 12
Brussels 11
New York 11
Helsinki 10
Boardman 9
Shenyang 9
Tianjin 9
Changsha 8
Guangzhou 8
Hebei 8
Ningbo 8
Bucheon-si 7
Redmond 7
Dong Ket 5
Haikou 5
Hangzhou 5
Nanchang 5
Seoul 5
Zhengzhou 5
Cagliari 4
Falls Church 4
Lanzhou 4
Los Angeles 4
Milan 4
Redwood City 4
Taizhou 4
Venezia 4
Auburn Hills 3
Bologna 3
Chennai 3
Chicago 3
Como 3
Dallas 3
Genova 3
Jiaxing 3
Norwalk 3
Padova 3
Rome 3
Seattle 3
Clearwater 2
Dubai 2
Edinburgh 2
Fairfield 2
Florence 2
Fremont 2
Kemerovo 2
Kochi 2
Lappeenranta 2
Orgiano 2
Ramsis 2
Sindelfingen 2
Taiyuan 2
Vienna 2
Washington 2
Weimar 2
Xi'an 2
Athens 1
Banha 1
Bari 1
Bishkek 1
Bolzano 1
Casalserugo 1
Changchun 1
Council Bluffs 1
Crotone 1
Dalian 1
Delhi 1
Edmond 1
Frankfurt am Main 1
Fuzhou 1
Grado 1
Hyderabad 1
Kunming 1
Madrid 1
Miami 1
Mirano 1
Modugno 1
Montebelluna 1
Riva 1
Riyadh 1
San Francisco 1
San Salvatore Monferrato 1
Santa Clara 1
Totale 1.370
Nome #
CHRONIC VIRAL HEPATITIS: FACTORS INFLUENCING LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS B AND RESPONSE TO THERAPY IN CHRONIC HEPATITIS C 139
Efficacy and safety of oral DAAs HCV therapy in the elderly 121
Progression to cirrhosis and mortality of chronic hepatiita type B: a cohort study with 25 years follow-up in Italy. 110
TLR4 rs4986790 A>G genetic polymorphisms predict liver fibrosis severity in Caucasian patients with chronic hepatitis C. 110
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. 109
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 104
Interaction between vitamin D binding protein polymorphisms and vitamin D levels in the prediction of antiviral response in chronic hepatitis C. 102
Sofosbuvir plus ribavirin for difficult to treat HCV-2: improved efficacy with extended treatment duration. 97
HCV gentotype 3 and circulating squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV infected patients. 96
Interaction between vitamin D binding protein polymorphisms and vitamin D levels in the prediction of antiviral response in chronic hepatitis C. 89
Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C 89
Genetic polymorphysms of vitamin d pathway predict antiviral treatment outcome in slow responder naive patients with chronic hepatitis C 85
TLR4 rs4986790 A>G . genetic polymorphisms predict liver fibrosis severity in Caucasian patients with chronic hepatitis B. 83
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome 82
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C 77
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C 72
Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily clinical parameters. 69
Progression to cirrhosis, hepatocellular carcinoma and liver related mortality in chronic hepatitis B patients in Italy. 68
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis 52
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 37
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 19
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 10
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 9
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 9
Totale 1.838
Categoria #
all - tutte 5.434
article - articoli 3.267
book - libri 0
conference - conferenze 1.883
curatela - curatele 0
other - altro 284
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 4 5 35 5 19 22 5 14 21 42 33
2020/2021203 19 46 9 40 16 20 4 8 1 4 21 15
2021/2022171 13 58 1 10 17 6 9 8 5 4 14 26
2022/2023392 21 38 41 56 41 113 0 31 32 5 12 2
2023/2024193 8 16 5 11 17 23 13 25 2 9 52 12
2024/202548 19 29 0 0 0 0 0 0 0 0 0 0
Totale 1.838